Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 15/20 | 0.62 |
| ▸ | CTSL | P07711 | 14/20 | 0.62 |
| ▸ | CTSB | P07858 | 9/20 | 0.61 |
| ▸ | CTSK | P43235 | 8/20 | 0.61 |
| ▸ | TACR1 | P25103 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.57 |
| ▸ | ELANE | P08246 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6312473 | 1.00 | CTSS (0.62) | CTSSCTSLCTSBCTSKTACR1 | |
| SCHEMBL6311738 | 1.00 | CTSS (0.62) | CTSSCTSLCTSBCTSKTACR1 | |
| SCHEMBL3516129 | 0.86 | ATM (0.58) | CTSSCTSLCTSBCTSKTACR1 | |
| SCHEMBL3516128 | 0.86 | ATM (0.58) | CTSSCTSLCTSBCTSKTACR1 | |
| SCHEMBL4561240 | 0.86 | ATM (0.58) | CTSSCTSLCTSBCTSKTACR1 | |
| SCHEMBL14283757 | 0.86 | CTSK (0.77) | CTSSCTSLCTSBCTSK | |
| SCHEMBL6311222 | 0.85 | CTSL (0.60) | CTSSCTSLCTSBCTSKTACR1 | |
| SCHEMBL16492789 | 0.85 | CTSS (0.60) | CTSSCTSLCTSBCTSKTACR1 | |
| SCHEMBL6311227 | 0.85 | CTSL (0.60) | CTSSCTSLCTSBCTSKTACR1 | |
| SCHEMBL6320730 | 0.85 | CTSL (0.60) | CTSSCTSLCTSBCTSKTACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3687988-B1 | ANTIBACTERIAL COMPOUND AND USES OF SAME | BIOMERIEUX SA (FR) | 2023-05-03 | — | — | EP | disclosed |
| US-11414403-B2 | Antibacterial compound and uses of same | BIOMERIEUX (FR) | 2022-08-16 | — | — | US | disclosed |
| US-20200277281-A1 | ANTIBACTERIAL COMPOUND AND USES OF SAME | bioMérieux (FR) | 2020-09-03 | — | — | US | disclosed |
| EP-3687988-A1 | ANTIBACTERIAL COMPOUND AND USES OF SAME | bioMérieux (FR) | 2020-08-05 | — | — | EP | disclosed |
| US-20050250765-A1 | Diazepinones as antiviral agents | CHO HIDETSURA | 2005-11-10 | — | — | US | disclosed |
| US-20040116410-A1 | Diazepinones as antiviral agents | CHO HIDETSURA (JP) | 2004-06-17 | — | — | US | disclosed |
| WO-2002014324-A2 | DIAZEPINONES AS ANTIVIRAL AGENTS | WARNER-LAMBERT COMPANY (US) | 2002-02-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050250765-A1 | Diazepinones as antiviral agents | ZC3HAV1, ECI1, ZC3HAV1L | CTSS 2164/4885CTSL 4145/4885CTSB 1890/4885 |
| US-20200277281-A1 | ANTIBACTERIAL COMPOUND AND USES OF SAME | GLUL, PGLS, TGM3 | CTSS 1170/4885CTSL 110/4885CTSB 923/4885 |
| US-11414403-B2 | Antibacterial compound and uses of same | GLUL, PGLS, TGM3 | CTSS 1170/4885CTSL 110/4885CTSB 923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.